PTC Therapeutics Announces Positive Phase 2 Results For PTC124 In Cystic Fibrosis
Sat, 04 Nov 2006 08:00 AM EST
... PTC Therapeutics, Inc. (PTC), a biopharmaceutical company focused on the discovery and development of small-molecule drugs targeting post-transcriptional control processes, today announced the findings from two Phase 2 clinical trials of PTC124 in patients with cystic fibrosis (CF) due to a nonsense mutation. [click link for full article] ...
Related Topics
- Cystic Fibrosis
- Pulmonary Fibrosis
- Cystic Hygroma
- Pharmacology
- Food Recommendations: South Beach Diet - Phase 2
- Food Recommendations: South Beach Diet - Phase 1
- Tb
- Fibrosis
- Mastitis
- Interstitial pulmonary fibrosis
- Prenatal Testing
- Genes and Gene Therapy
- HLA-B27
- Triple Screen
- Acne
- TB Skin Test
- Clinical Trials
- CK
- Periventricular Leukomalacia
- Epidural

Not Signed In -


